Coronavirus Latest Updates

  • Printer Friendly Version
  • Decrease Text Size
  • Increase Text Size
  • PDF

Thrombosis and Hemostasis

Thrombosis & Hemostasis

Our team is dedicated to treat children with bleeding and clotting problems. Team includes physicians, nurses and social workers, with special interest in hemophilia and coagulation factor deficiencies. We also dedicate our care to children with clotting disorders. Beyond the care of children afflicted with these conditions, we also consider family education, social interactions among families of affected children, home care and support as the goal of our team to help parents and families with their inevitable emotional challenges.

We engage in ongoing research for developing innovative therapies and for addressing safety issues, e.g. complications or risks that may be associated with medications. We educate and mentor future trainees in diagnosis and treatment of children and adolescents with bleeding and clotting disorders, and treatment.

Our team is dedicated to care for children with bleeding problems such as:

  • Congenital or acquired bleeding disorders [Our Clinical TrialsPatient Information ]:
    • Hemophilia A (Classical Hemophilia-factor VIII deficiency)
    • Hemophilia B (Christmas disease, factor IX deficiency)
    • Hemophilia C (Factor XI deficiency)
    • Von Willebrand’s disease
  • Rare clotting factor deficiencies [Our Clinical TrialsPatient Information ]:
    • Factor I (fibrinogen deficiency, known as afibrinogenemia or dysfibrinogenemia/hypofibrinogenemia)
    • Factor II (prothrombin)
    • Factor V (parahemophilia)
    • Factor VII
    • Factor X (Stuart factor)
    • Factor XII (Hageman factor)
    • Factor XIII
  • Disorders of the platelets [Our Clinical TrialsPatient Information]:
    • Hermansky-Pudlak syndrome
    • Wiskott Aldrich syndrome
    • Gray platelet syndrome
    • Alpha granule deficiency
    • Bernard Soulier Syndrome or disorders involving fibrinolytic system (e.g. PAI-I deficiency or alpha-2 antiplasmin deficiency)
  • Inherited Disorders of Thrombosis [Our Clinical TrialsPatient Information]:
    • Protein C
    • Protein S
    • Anti-thrombin-III
    • Factor V Leiden
    • Prothrombin gene mutation
    • Anti-phospholipid antibodies
    • Lipoprotein-A
    • Homocysteinemia
    • Elevated fibrinogen
    • Factors VIII, IX, XI
    • Low factor XII


Unique Features:

  • All coagulation studies, platelet function tests, and thrombophilia tests are done at the “Special Hematology Laboratory” at Westchester Medical Center
  • Comprehensive Genetics Diagnostics
  • Comprehensive Hemophilia Network
  • Personalized and Customized Care


Research and Education Highlights:

  • We participate in clinical trials of new factor products which enables us to try new innovative therapies in children with hemophilia.
  • Student, resident and other allied health professional elective training
Pediatric Hematology/Oncology
Maria Fareri Children’s Hospital
100 Woods Road
Valhalla, NY 10595

By Car


Maria Fareri Children’s Hospital is served by Metro North's Harlem line via two stations:

• White Plains - Bus transfer options available
• Hawthorne - Taxi service available

For train fare and schedule information, call 1-800-METRO-INFO or go to METRO NORTH 


There are three bus lines (Westchester Bee Line) you can take to our campus. Please call 914.813.7777 for bus routes and fares.

Campus Map

The Westchester Medical Center campus includes the Maria Fareri Children's Hospital and the Behavioral Health Center.

Tugal, Oya
Pediatric Hematology-Oncology


Social Work:
Rose Bartone, LCSW-R
(914) 594-2159